NBS

Neostem, Inc. News Headlines

$5.98
*  
0.03
0.5%
Get NBS Alerts
*Delayed - data as of Jul. 23, 2014  -  Find a broker to begin trading NBS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Neostem To Present At Oncology Partnering And Deal Making;Webcast At 5:05 PM ET
7/7/2014 3:00:00 PM - RTT News

Neostem To Present At Jefferies Healthcare Conference; Webcast At 11:30 AM ET
6/2/2014 10:30:00 AM - RTT News

NeoStem Records Better 5-year Survival Rates With Melapuldencel-T Immunotherapy
5/29/2014 8:23:00 AM - RTT News

Sector Update: Health Care
5/19/2014 8:38:20 AM - MT Newswires

Sector Update: Health-Care Shares Rise Pre-Market; NeoStem Granted Two European Patents
5/19/2014 8:36:27 AM - MT Newswires

Should You Sell In May?
4/28/2014 10:49:00 AM - Seeking Alpha

Should You Sell In May?
4/28/2014 10:33:30 AM - SeekingAlpha

Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatment
4/14/2014 8:19:28 AM - MT Newswires

Sector Update: Healthcares
4/14/2014 8:19:03 AM - MT Newswires

Despite April 2014's Issue Of 'Journal Of The American College Of Cardiology,' NeoStem's AMR-001 Maintains Its Leverage For Stem Cell Based MI Treatment
4/6/2014 8:57:00 AM - Seeking Alpha

NeoStem's Alliance With Baxter Should Make Investors Very Happy In The Near Future
3/25/2014 7:58:00 AM - Seeking Alpha

Osiris Therapeutics: Poised For Another Breakout
3/11/2014 2:07:00 AM - Seeking Alpha

Zeiher Study Likely Predicts The Outcome Of NeoStem's AMR-001 Trial
3/10/2014 10:48:00 AM - Seeking Alpha

2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
2/24/2014 9:42:00 AM - Seeking Alpha

Cesca Merger Imminent: Path To 2x+ Returns Appears Achievable
2/10/2014 2:42:00 PM - Seeking Alpha

Is There Investment Upside In The Future Of Treating Diabetes?
2/10/2014 8:01:00 AM - Seeking Alpha

Contract Manufacturing: Often Ignored, But Potentially Profitable
2/3/2014 12:04:00 PM - Seeking Alpha

A Comprehensive Look At Athersys
2/3/2014 10:12:00 AM - Seeking Alpha

Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (1/31/14)
2/2/2014 6:41:00 AM - Seeking Alpha

Could PCT Be NeoStem's Breakout Star?
1/27/2014 12:06:00 PM - Seeking Alpha

Clearing Up Misconceptions About NeoStem's AMR-001
1/22/2014 12:52:00 PM - Seeking Alpha

ThermoGenesis Merging With TotiRx - Heating Up Cell Therapy Mergers And Acquisitions
1/21/2014 3:33:00 PM - Seeking Alpha

3 Small Biotech Companies Poised For Big Growth In 2014
1/21/2014 1:07:00 PM - Seeking Alpha

Neostem Could Rally On Phase II Results
1/8/2014 5:36:00 AM - Seeking Alpha

4 Stocks That Could See Significant Gains In 2014
1/6/2014 2:35:00 PM - Seeking Alpha